Institute for Clinical and Economic Review Releases Evidence Report on Therapies for IgA Nephropathy
February 09, 2026
February 09, 2026
BOSTON, Massachusetts, Feb. 9 (TNSrpt) -- The Institute for Clinical and Economic Review issued the following news release:
* * *
Institute for Clinical and Economic Review Releases Evidence Report on Therapies for IgA Nephropathy
-- All three therapies exhibit net health benefits, but uncertainties remain around the magnitude of long-term improvements in outcomes as well as safety; sibeprenlimab's price far exceeds usual thresholds for cost-effectiven . . .
* * *
Institute for Clinical and Economic Review Releases Evidence Report on Therapies for IgA Nephropathy
-- All three therapies exhibit net health benefits, but uncertainties remain around the magnitude of long-term improvements in outcomes as well as safety; sibeprenlimab's price far exceeds usual thresholds for cost-effectiven . . .